Compare CSBR & REKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSBR | REKR |
|---|---|---|
| Founded | 1985 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.0M | 96.5M |
| IPO Year | 2015 | 2017 |
| Metric | CSBR | REKR |
|---|---|---|
| Price | $5.89 | $0.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.4K | ★ 2.2M |
| Earning Date | 03-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 161.11 | 4.35 |
| EPS | ★ N/A | N/A |
| Revenue | $2,900,000.00 | ★ $9,234,000.00 |
| Revenue This Year | $4.84 | $12.51 |
| Revenue Next Year | $11.51 | $23.49 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.50 | $0.60 |
| 52 Week High | $9.63 | $3.42 |
| Indicator | CSBR | REKR |
|---|---|---|
| Relative Strength Index (RSI) | 45.13 | 48.24 |
| Support Level | N/A | $0.60 |
| Resistance Level | $6.31 | $0.92 |
| Average True Range (ATR) | 0.43 | 0.04 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 10.49 | 71.03 |
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Rekor Systems Inc is a roadway intelligence company focused on modernizing public safety, urban mobility, and transportation management through solutions. The company delivers services and solutions that collect, connect, and organize mobility data, providing real-time insights to support decision making, enhance situational awareness, enable rapid response, and support predictive analytics. The Company derives its revenues mainly from the licensing and sale of its roadway data and traffic management product and service offerings. These offerings include a mixture of data collection, implementation, engineering, customer support, and maintenance services, as well as software and hardware. The company operates in the United States and other regions.